The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IWWM-11 2022 | The impact of booster vaccinations on SARS-CoV-2 antibody levels in patients with WM
Lee Greenberger, PhD, Leukemia & Lymphoma Society, New York, NY, discusses the impact of COVID-19 booster vaccinations on serum antibody levels in patients with Waldenström’s macroglobulinemia (WM), and further emphasizes the precautions that should be taken by these immunocompromised patients to prevent infection. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
